GEOMETRY Clinical Trials Program ?Global information

Learn about the GEOMETRY clinical trials, research program, studying capmatinib (INC280) in patients with advanced NSCLC who have received one or two prior therapies.

cancer clinical trials, EGFR, epidermal growth factor receptor, capmatinib, cmet amplification, c-met amplification, cmet gcn, c-met gcn, cmet gene copy number, c-met gene copy number, cmet inhibitor, c-met inhibitor, cmet mutation, c-met mutation, GEOMET


Last Update: MEZ/CET 23.08.2017, 01:13:04 Uhr |